interactions are bridging human NK cells with plasmacytoid and monocyte derived dendritic cells during innate immune responses. Blood 2006;108:3851–3858.
59Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T: Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 2004;101:16606–16611.
60Moretta A, Marcenaro E, Sivori S, DellaChiesa M, Vitale M, Moretta L: Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol 2005;26:668–675.
61Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M: Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999;5:405–411.
62Piccioli D, Sbrana S, Melandri E, Valiante NM: Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002;195:335–341.
63Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Münz C: Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002;195:343–351.
64Rydyznski CE, Cranert SA, Zhou JQ, Xu H, Kleinstein SH, Singh H, Waggoner SN: Affinity maturation is impaired by natural killer cell suppression of germinal centers. Cell Rep 2018;24:3367–3373.e4.
65Gounder SS, Abdullah BJJ, Radzuanb NEIBM, Zain FDBM, Sait NBM, Chua C, Subramani B: Effect of aging on NK cell population and their proliferation at ex vivo culture condition. Anal Cell Pathol (Amst) 2018;2018:7871814.
66Della Chiesa M, Marcenaro E, Sivori S, Carlomagno S, Pesce S, Moretta A: Human NK cell response to pathogens. Semin Immunol 2014;26:152–160.
67Raulet DH, Guerra N: Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol 2009;9:568–580.
68Rodier F, Campisi J: Four faces of cellular senescence. J Cell Biol 2011;192:547–556.
69Camous X, Pera A, Solana R, Larbi A: 2012. NK cells in healthy aging and age-associated diseases. J Biomed Biotechnol 2012;2012:195956.
70Solana R, Campos C, Pera A, Tarazona R: Shaping of NK cell subsets by aging. Curr Opin Immunol 2014;29:56–61.
71Campos C, Pera A, Sanchez-Correa B, Alonso C, Lopez-Fernandez I, Morgado S, Tarazona R, Solana R: Effect of age and CMV on NK cell subpopulations. Exp Gerontol 2014;54:130–137.
72Al-Attar A, Presnell SR, Peterson CA, Thomas DT, Lutz CT: The effect of sex on immune cells in healthy aging: Elderly women have more robust natural killer lymphocytes than do elderly men. Mech Ageing Dev 2016;156:25–33.
73Reed RG, Al-Attar A, Presnell SR, Lutz CT, Segerstrom SC: A longitudinal study of the stability, variability, and interdependencies among late-differentiated T and NK cell subsets in older adults. Exp Gerontol 2019;121:46–54.
74Reed RG, Presnell SR, Al-Attar A, Lutz CT, Segerstrom SC: Perceived stress, cytomegalovirus titers, and late-differentiated T and NK cells: between-, within-person associations in a longitudinal study of older adults. Brain Behav Immun 2019;80:266–274.
75Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T: Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol 2012;24:331–341.
76Campos C, Pera A, Lopez-Fernandez I, Alonso C, Tarazona R, Solana R: Proinflammatory status influences NK cells subsets in the elderly. Immunol Lett 2014;162:298–302.
77Mariani E, Meneghetti A, Neri S, Ravaglia G, Forti P, Cattini L, Facchini A: Chemokine production by natural killer cells from nonagenarians. Eur J Immunol 2002;32:1524–1529.
78Wang J, Geiger H, Rudolph KL: Immunoaging induced by hematopoietic stem cell aging. Curr Opin Immunol 2011;23:532–536.
79Solana R, Mariani E: NK and NK/T cells in human senescence. Vaccine 2000;18:1613–1620.
80Sanchez-Correa B, Morgado S, Gayoso I, Bergua JM, Casado JG, Arcos MJ, Bengochea ML, Duran E, Solana R, Tarazona R: Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands. Cancer Immunol Immunother 2011;60:1195–1205.
81Sanchez-Correa B, Gayoso I, Bergua JM, Casado JG, Morgado S, Solana R, Tarazona R: Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients. Immunol Cell Biol 2012;90:109–115.
82Tarazona R, Campos C, Pera A, Sanchez-Correa B, Solana R: Flow cytometry analysis of NK cell phenotype and function in aging. Methods Mol Biol 2015;1343:9–18.
83Mariani E, Mariani AR, Meneghetti A, Tarozzi A, Cocco L, Facchini A: Age-dependent decreases of NK cell phosphoinositide turnover during spontaneous but not Fc-mediated cytolytic activity. Int Immunol 1998;10:981–989.
84Campos C, López N, Pera A, Gordillo JJ, Hassouneh F, Tarazona R, Solana R: Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age. Biogerontology 2015;16:671–683.
85Bigley AB, Spielmann G, Agha N, O’Connor DP, Simpson RJ: Dichotomous effects of latent CMV infection on the phenotype and functional properties of CD8+ T-cells and NK-cells. Cell Immunol 2016;300:26–32.
86López-Botet M, Muntasell A, Vilches C: The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection. Semin Immunol 2014;26:145–151.
87Gumá M, Angulo A, Vilches C, Gómez-Lozano N, Malats N, López-Botet M: Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004;104:3664–3671.
88Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O: The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat Immunol 2010;11:121–128.